ALCORN HARRY W JR
SEC CIK 1186761 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Senior VP, Clinical Ops | 43.6K | $121.0K | — | 3 | 2021-08-16 | 2021-09-15 |
Most active insiders at DMAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRILL AB | 10% | $7.63M | — |
| 2 | Semba Charles Pauling | Dir | — | — |
| 3 | Pauls Dietrich John | Pres, CEO, Dir | — | — |
| 4 | Parsons James T. | Dir | — | — |
| 5 | Giuffre Randall Michael | Dir | — | — |
ALCORN HARRY W JR made no open-market trades at DMAC in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-15 | 2021-09-15 | DMAC | DiaMedica Therapeutics Inc. | ALCORN HARRY W JR | SVP, Clinical Ops | P - Purchase | $3.80 | +15.0K | 43.6K | +52% | +$57.0K | |
| I | 2021-08-16 | 2021-08-16 | DMAC | DiaMedica Therapeutics Inc. | ALCORN HARRY W JR | Senior VP, Clinical Ops | P - Purchase | $3.07 | +399 | 399 | New | +$1,225 |
| M | 2021-08-16 | 2021-08-16 | DMAC | DiaMedica Therapeutics Inc. | ALCORN HARRY W JR | Senior VP, Clinical Ops | P - Purchase | $3.09 | +20.3K | 28.3K | +256% | +$62.8K |
Purchase Sale Sale after option exercise All abbreviations